HYBRID + WITH TRANSLATION

General session 5

Coordinator:
RICARDO CAPONERO (BRA)

Discussants:
VERA APARECIDA SADDI (BRA)
EDUARDO CARVALHO PASSOA (BRA)

Daniele Assad Suzuki (BRA)

Adherence to endocrine adjuvant therapy in women with early hormone positive breast cancer

DANIELE ASSAD SUZUKI (BRA)

Leonardo Ribeiro Soares (BRA)

Incidence of Interstitial Lung Disease and Cardiotoxicity with Trastuzumab-Deruxtecan in Breast Cancer patients: a systematic review and single-arm meta-analysis

LEONARDO RIBEIRO SOARES (BRA)

Martina Lichtenfels (BRA

Drug resistance in luminal breast tumors: results of a novel in vitro breast cancer chemoresistance platform

MARTINA LICHTENFELS (BRA)

Martina Lichtenfels (BRA)

Discussion

Mini conference: The treatment future of hormone positive advanced breast cancer

Chairman:
GABRIEL FELIPE SANTIAGO (BRA)
Speaker:
ROMUALDO BARROSO DE SOUSA (BRA)

Discussion

Deidimar Cassia Batista Abreu (BRA)

Gold Satellite Symposium - Grupo Fleury: Genetic deep-dive on Breast Oncology

DEIDIMAR CÁSSIA BATISTA ABREU (BRA)

Coffee Break

Silver Satellite Symposium - Pfizer: Real-world data use in clinical practice. Studies overview on Metastatic Breast Cancer HR+/HER2-

Chairman:
ANA KAROLINA DE SANTANA NUNES (BRA)

Speaker:
LUCIANO MORGANTI PALADINI (BRA)

Mini conference: New evidence of locoregional approach in metastatic patient

Chairman:
LUIS ONOFRE REZENDE DE CARVALHO (BRA)
Speaker:

Discussion

Lecture: The best of breast cancer in the last 12 months (ASCO 2022, SABS 2022 and BBCS 2023)

Chairwoman:  ANDREA ARREDONDO (BRA)
Speaker 1: 25’ Systemic - CARLOS HENRIQUE DOS ANJOS (BRA)
Speaker 2: 25’ Loco regional - GUILHERME NOVITA GARCIA (BRA)

Awarding and closing remarks

RICARDO CAPONERO (BRA)
ROSEMAR MACEDO SOUSA RAHAL (BRA)